ES8705411A1 - Procedimiento para preparar derivados de 1-piperazinacarboxamida - Google Patents

Procedimiento para preparar derivados de 1-piperazinacarboxamida

Info

Publication number
ES8705411A1
ES8705411A1 ES535027A ES535027A ES8705411A1 ES 8705411 A1 ES8705411 A1 ES 8705411A1 ES 535027 A ES535027 A ES 535027A ES 535027 A ES535027 A ES 535027A ES 8705411 A1 ES8705411 A1 ES 8705411A1
Authority
ES
Spain
Prior art keywords
formula
compound
preparation
pharmaceutical compositions
carboxamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535027A
Other languages
English (en)
Other versions
ES535027A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia Animal Health Inc
Original Assignee
Ferrosan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan AB filed Critical Ferrosan AB
Publication of ES535027A0 publication Critical patent/ES535027A0/es
Publication of ES8705411A1 publication Critical patent/ES8705411A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 1-PIPERAZINACARBOXAMIDA, DE FORMULA (I) Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R4-NC-A, PARA OBTENER UN COMPUESTO DE FORMULA (I), EN LAS QUE A Y Z REPRESENTAN OXIGENO O AZUFRE, Y X, Y, R1-R4 PUEDEN SER VARIOS TIPOS DE RADICALES. LA REACCION SE EFECTUA EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y 110JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE PSICOSIS Y DEPRESION.
ES535027A 1983-08-10 1984-08-09 Procedimiento para preparar derivados de 1-piperazinacarboxamida Expired ES8705411A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8304361A SE8304361D0 (sv) 1983-08-10 1983-08-10 Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives

Publications (2)

Publication Number Publication Date
ES535027A0 ES535027A0 (es) 1987-05-01
ES8705411A1 true ES8705411A1 (es) 1987-05-01

Family

ID=20352166

Family Applications (3)

Application Number Title Priority Date Filing Date
ES535027A Expired ES8705411A1 (es) 1983-08-10 1984-08-09 Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES552001A Expired ES8704917A1 (es) 1983-08-10 1986-02-14 Procedimiento para prepararar derivados de 1-piperazinacarboximida.
ES556989A Expired ES8802039A1 (es) 1983-08-10 1986-08-01 Procedimiento par preparar derivados de 1-piperazinacarboxamida

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES552001A Expired ES8704917A1 (es) 1983-08-10 1986-02-14 Procedimiento para prepararar derivados de 1-piperazinacarboximida.
ES556989A Expired ES8802039A1 (es) 1983-08-10 1986-08-01 Procedimiento par preparar derivados de 1-piperazinacarboxamida

Country Status (16)

Country Link
US (1) US4935419A (es)
EP (1) EP0136274B1 (es)
JP (1) JPH0723364B2 (es)
AT (1) ATE47850T1 (es)
AU (1) AU569537B2 (es)
CA (1) CA1253148A (es)
DE (1) DE3480395D1 (es)
DK (1) DK157864C (es)
ES (3) ES8705411A1 (es)
FI (1) FI80449C (es)
HU (1) HU196977B (es)
IE (1) IE58065B1 (es)
IL (1) IL72563A (es)
NZ (1) NZ209166A (es)
SE (1) SE8304361D0 (es)
WO (1) WO1985000811A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
CA1326451C (en) * 1988-01-26 1994-01-25 Nippon Chemiphar Co., Ltd. Therapeutic agent for liver disease and piperazine derivatives
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
US5719156A (en) * 1995-05-02 1998-02-17 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5968929A (en) * 1996-10-30 1999-10-19 Schering Corporation Piperazino derivatives as neurokinin antagonists
US6355643B1 (en) 1999-03-03 2002-03-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US20100093935A1 (en) * 2008-10-15 2010-04-15 Nitto Denko Corporation Method of preparing polyglutamate conjugates
JP2013514443A (ja) * 2009-12-16 2013-04-25 日東電工株式会社 ポリグルタミン酸の制御された合成
ES2727815T3 (es) * 2012-04-14 2019-10-18 Intra Cellular Therapies Inc Tratamiento del TEPT y de trastornos del control de impulsos
BR112018015283B1 (pt) 2016-01-26 2023-09-26 Intra-Cellular Therapies, Inc Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
WO2018126143A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000892A (en) * 1959-11-16 1961-09-19 Paul A J Janssen 1-aroylalkyl-4-aroylpiperazines
DE1670431A1 (de) * 1966-03-04 1971-02-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung neuer Piperazin-Derivate
GB1143882A (es) * 1966-06-21
GB1186495A (en) * 1968-02-20 1970-04-02 Delalande Sa 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation
FR2262521A1 (en) * 1973-08-08 1975-09-26 Delalande Sa 3-(3,4,5-Trimethoxyphenyl)piperazines - with coronary vasodilator, hypotensive, antiinflammatory, analgesic, and antiulcer activity
AR207031A1 (es) * 1974-03-06 1976-09-09 Kyorin Seiyaku Kk Procedimiento para preparacion de nuevos derivados de 1-(3-fenilpropil)-4-furoilpiperacina
JPS5143772A (en) * 1974-09-26 1976-04-14 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 furoirupiperajinjudotaino seizoho
JPS50131974A (es) * 1974-03-06 1975-10-18
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) * 1976-10-07 1978-04-27 Kyorin Seiyaku Kk Piperadine derivative
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
WO1981003658A1 (en) * 1980-06-16 1981-12-24 Ferrosan Ab Diphenylbutyl-1-acylpiperazines
JPS58502056A (ja) * 1981-12-02 1983-12-01 アクチ−ボラグ　フエロサン １−ピペラジノカルボキシレ−ト、それらの製造方法およびそれらを含む医薬組成物

Also Published As

Publication number Publication date
HUT37415A (en) 1985-12-28
AU569537B2 (en) 1988-02-04
DK157864C (da) 1990-07-23
US4935419A (en) 1990-06-19
EP0136274A1 (en) 1985-04-03
EP0136274B1 (en) 1989-11-08
IE842050L (en) 1985-02-10
HU196977B (en) 1989-02-28
ES535027A0 (es) 1987-05-01
ES556989A0 (es) 1988-03-16
AU3211184A (en) 1985-03-12
ATE47850T1 (de) 1989-11-15
SE8304361D0 (sv) 1983-08-10
FI80449C (fi) 1990-06-11
DE3480395D1 (en) 1989-12-14
IE58065B1 (en) 1993-06-30
DK157485A (da) 1985-04-09
JPH0723364B2 (ja) 1995-03-15
DK157485D0 (da) 1985-04-09
JPS60501956A (ja) 1985-11-14
IL72563A0 (en) 1984-11-30
DK157864B (da) 1990-02-26
IL72563A (en) 1988-10-31
FI851350L (fi) 1985-04-03
WO1985000811A1 (en) 1985-02-28
ES552001A0 (es) 1987-04-16
FI851350A0 (fi) 1985-04-03
ES8802039A1 (es) 1988-03-16
NZ209166A (en) 1987-07-31
CA1253148A (en) 1989-04-25
ES8704917A1 (es) 1987-04-16
FI80449B (fi) 1990-02-28

Similar Documents

Publication Publication Date Title
ES8705411A1 (es) Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES8603408A1 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES8303421A1 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES8700254A1 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES8600263A1 (es) Un compuesto.
ES446993A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzofenona.
ES470916A1 (es) Ÿun procedimiento para la preparacion de derivados de acidos4-hidroxi-2-quinolinon-3-carboxilicosŸ
ES458721A1 (es) Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos.
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
YU47010B (sh) Derivati 1,6-naftiridina
ES8708136A1 (es) Procedimiento para la obtencion de derivados de acido barbiturico
ES8706644A1 (es) Un procedimiento para preparar derivados de dihidropiridazina
GB1516793A (en) 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivative several processes for its preparation and its use as a coronary therapeutic agent
ES466127A1 (es) Un procedimiento para la preparacion de l-formil-indol-dihi-droindol dimero.
ES435955A1 (es) Un procedimiento para obtener un derivado de pirido (3,4-d) piridezina.
ES8601910A1 (es) Un procedimiento para preparar nuevos derivados amidinicos de 4-fenilimidazol sustituido en la posicion 2
LV5491A3 (lv) 2-tiazolidinona atvasinajumu iegusanas panemiens
ES449777A1 (es) Un procedimiento para la preparacion de n-(5-tetrazolil)-pi-rimido (1, 2-a) quinolin-2-carboxamidas.
ES8606273A1 (es) Un procedimiento para la preparacion de compuestos de 2- oxindol
JPS5279081A (en) Preparation of novel 7-methoxycephalosporins
ES8302686A1 (es) Procedimiento para la obtencion de un nuevo derivado furanico de interes terapeutico.
ES8303380A3 (es) "procedimiento para la preparacion del 1,1-dioxidos de 4-hidroxi-2h-1,2-benzotiazina-3-3-carboxamina".
ES8302685A1 (es) Procedimiento para la obtencion de un nuevo derivado de furano terapeuticamente activo.
ES8704151A1 (es) Procedimiento para la preparacion de derivados de n-acil-l- prolina
ES432535A1 (es) Un procedimiento para la preparacion de benzodiazepinas-1,4.

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20050124